ArticleInformatics in medicine unlocked2022
Risk assessment in COVID-19 patients: A multiclass classification approach.
Article in Informatics in medicine unlocked, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Understanding SARS-CoV-2 infection that causes COVID-19 disease among the population was fundamental to determine the risk factors associated with severe cases or even death. Amidst the study of the pandemic, Artificial Intelligence (AI) and Machine Learning (ML) have been successfully applied in many areas such as biomedicine. Using a dataset from the Mexican Ministry of Health, we performed a multiclass classification scheme for the detection of risks in COVID-19 patients and implemented three Machine Learning algorithms achieving the following accuracy measures: Random Forest (89.86%), GBM (89.37%) XGBoost (89.97%). The key findings are the identification of relevant components associated with different severities of COVID-19 disease. Among these factors, we found sex, age, days elapsed from the beginning of symptoms, symptoms such as dyspnea and polypnea; and other comorbidities such as diabetes and hypertension. This setting allows us to establish predicting algorithms to model the risk that an individual or a specific group of people face after contracting COVID-19 and the factors associated with developing complications or receiving appropriate treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.